BLGO vs. NB, ASM, VOXR, USGO, AREC, GAMC, HYMC, VGZ, AMLI, and PLG
Should you be buying BioLargo stock or one of its competitors? The main competitors of BioLargo include NioCorp Developments (NB), Avino Silver & Gold Mines (ASM), Vox Royalty (VOXR), U.S. GoldMining (USGO), American Resources (AREC), Golden Arrow Merger (GAMC), Hycroft Mining (HYMC), Vista Gold (VGZ), American Lithium (AMLI), and Platinum Group Metals (PLG). These companies are all part of the "basic materials" sector.
NioCorp Developments (NASDAQ:NB) and BioLargo (NASDAQ:BLGO) are both small-cap basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, media sentiment, dividends, earnings, institutional ownership, community ranking and risk.
NioCorp Developments currently has a consensus target price of $12.00, suggesting a potential upside of 404.20%. Given BioLargo's higher probable upside, analysts plainly believe NioCorp Developments is more favorable than BioLargo.
In the previous week, NioCorp Developments had 1 more articles in the media than BioLargo. MarketBeat recorded 1 mentions for NioCorp Developments and 0 mentions for BioLargo. BioLargo's average media sentiment score of 0.00 equaled NioCorp Developments'average media sentiment score.
BioLargo is trading at a lower price-to-earnings ratio than NioCorp Developments, indicating that it is currently the more affordable of the two stocks.
BioLargo received 108 more outperform votes than NioCorp Developments when rated by MarketBeat users. However, 75.00% of users gave NioCorp Developments an outperform vote while only 60.99% of users gave BioLargo an outperform vote.
NioCorp Developments has a beta of -0.52, indicating that its share price is 152% less volatile than the S&P 500. Comparatively, BioLargo has a beta of 0.26, indicating that its share price is 74% less volatile than the S&P 500.
4.0% of NioCorp Developments shares are owned by institutional investors. Comparatively, 0.0% of BioLargo shares are owned by institutional investors. 18.7% of NioCorp Developments shares are owned by insiders. Comparatively, 19.0% of BioLargo shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Summary
NioCorp Developments beats BioLargo on 6 of the 11 factors compared between the two stocks.
Get BioLargo News Delivered to You Automatically
Sign up to receive the latest news and ratings for BLGO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BLGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
BioLargo Competitors List
Related Companies and Tools
